Printer Friendly

Excellent news for sufferers.

FAZAKERLEY Hospital is bidding to become a global centre of excellence for arthritis treatment.

Professor Robert Moots, 42,newly appointed professor of rheumatology at the University of Liverpool, today revealed his plan for the development of the hospital's specialist treatment unit.

Merseyside was until 1997 the only region not to have a dedicated rheumatology research unit.

But Prof Moots today insisted the hospital's partnership with the university could lead to the development of the ``best and newest'' arthritis treatments.

And he claimed new side-effect free drugs could soon be in the pipeline.

Prof Moots, who is also consultant rheumatologist at Fazakerley hospital, said: ``Now Merseyside patients can be the first in the world to receive the best and newest treatment for arthritis.

``New antibodies are being developed to suppress the inflammation of rheumatoid arthritis and the unit is developing a new way of treating arthritis.''
COPYRIGHT 2004 MGN Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Liverpool Echo (Liverpool, England)
Date:Feb 2, 2004
Words:145
Previous Article:Singer in hospital.
Next Article:The name game for Reds star.


Related Articles
Joint bid to help claims.
Josh back to school after op to beat gene timebomb; Hope for brothers after bone marrow transplant.
BUYING TIME FOR PATIENTS; Anti-cancer drug will be available on the NHS.
At long last, hope emerges for hundreds; Pleural plaques sufferers could finally win compensation.
Letter: Working together.
Cameron Diaz turns a cook on 'My Sister's Keeper' sets.
Bulimics 'are more impulsive than others'.
Gut worm may help treat asthma.
Cancer Accounts for Annual 30,000 Deaths in Iran.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters